Jeffrey Packman
Corporate Officer/Principal bei CLEMENTIA PHARMACEUTICALS INC
Profil
Jeffrey Packman is currently the Chief Development Officer at Clementia Pharmaceuticals, Inc. He previously held positions as Senior Director-Drug Development Operations at Oscient Pharmaceuticals Corp., Associate Director at PAREXEL International Corp., Director at Recycline, Inc., and Vice President-Drug Development Operations at FoldRx.
Pharmaceuticals LLC.
He was also the Chief Development Officer at Apofore Corp.
from 2012 to 2013.
Mr. Packman received his undergraduate degree from Colby College and his MBA from F.W.
Olin Graduate School of Business.
Aktive Positionen von Jeffrey Packman
| Unternehmen | Position | Beginn |
|---|---|---|
| CLEMENTIA PHARMACEUTICALS INC | Corporate Officer/Principal | 01.11.2013 |
Ehemalige bekannte Positionen von Jeffrey Packman
| Unternehmen | Position | Ende |
|---|---|---|
Apofore Corp.
 Apofore Corp. Pharmaceuticals: MajorHealth Technology Apofore Corp. developed novel therapeutics for diabetes. The company was headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.10.2013 |
Recycline, Inc.
 Recycline, Inc. Wholesale DistributorsDistribution Services Recycline, Inc. recycles plastic scrap. Its products include bath, oral care, razors, travel, kitchen, food storage, tools, tabletop, straws, collections, cups, plates, bowls, cutlery, bags & totes, shareware, dopper, preserve compostables and UTEC cutting boards. The company was founded by Eric C. Hudson in 1996 and is headquartered in Waltham, MA. | Director/Board Member | - |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
| PAREXEL INTERNATIONAL CORPORATION | Director/Board Member | 25.04.2011 |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Jeffrey Packman
| Colby College | Undergraduate Degree |
| F.W. Olin Graduate School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
Recycline, Inc.
Recycline, Inc. Wholesale DistributorsDistribution Services Recycline, Inc. recycles plastic scrap. Its products include bath, oral care, razors, travel, kitchen, food storage, tools, tabletop, straws, collections, cups, plates, bowls, cutlery, bags & totes, shareware, dopper, preserve compostables and UTEC cutting boards. The company was founded by Eric C. Hudson in 1996 and is headquartered in Waltham, MA. | Distribution Services |
FoldRx Pharmaceuticals LLC
FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Health Technology |
Apofore Corp.
Apofore Corp. Pharmaceuticals: MajorHealth Technology Apofore Corp. developed novel therapeutics for diabetes. The company was headquartered in Cambridge, MA. | Health Technology |
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada. | Health Technology |
